Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Childhood Osteosarcoma”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Study completedNCT00070109
What this trial is testing

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Soft Tissue Sarcoma+2 more
Children's Oncology Group 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04803877
What this trial is testing

SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma in ChildrenOsteosarcoma Recurrent+1 more
Sarcoma Alliance for Research through Collaboration 48
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Study completedNCT00002825
What this trial is testing

Docetaxel in Treating Children With Recurrent Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00093821
What this trial is testing

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell TumorDisseminated Neuroblastoma+11 more
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT01586104
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

Who this might be right for
Adult RhabdomyosarcomaLung MetastasesMetastatic Ewing Sarcoma+9 more
Ann & Robert H Lurie Children's Hospital of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00043979
What this trial is testing

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00002515
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT02509234
What this trial is testing

Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

Who this might be right for
Recurrent Childhood Soft Tissue SarcomaRecurrent Ewing SarcomaRecurrent Rhabdomyosarcoma
Technical University of Munich 30
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00003023
What this trial is testing

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Ended earlyNCT04129151
What this trial is testing

Palbociclib + Ganitumab In Ewing Sarcoma

Who this might be right for
Ewing SarcomaEwing's Sarcoma Recurrent
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Ended earlyNCT04897880
What this trial is testing

Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT

Who this might be right for
Rhabdoid TumorAtypical Teratoid/Rhabdoid TumorMalignant Rhabdoid Tumor+1 more
Australian & New Zealand Children's Haematology/Oncology Group 25
Testing effectiveness (Phase 2)Study completedNCT00002738
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphomaSarcoma
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830667
What this trial is testing

CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat

Who this might be right for
Recurrent Childhood Ewing SarcomaRecurrent Childhood Malignant Solid NeoplasmRecurrent Childhood Rhabdomyosarcoma+9 more
Children's Oncology Group 79
Next Page